Patents by Inventor Kathy E. KARASIEWICZ-MENDEZ

Kathy E. KARASIEWICZ-MENDEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180298328
    Abstract: Provided herein are stimulated placental stem cells and methods of treating individuals having diseases or disorders of the circulatory system using stimulated placental cells. The invention also provides methods of inducing angiogenesis using such stimulated cells or populations of cells comprising such stimulated cells.
    Type: Application
    Filed: May 25, 2016
    Publication date: October 18, 2018
    Applicant: Celularity, Inc.
    Inventors: Kathy E. KARASIEWICZ-MENDEZ, Aleksandar FRANCKI, Jeffrey TURNER, Eric LAW, Jennifer PAREDES, Kristen LABAZZO, Hemlata RANA, Wolfgang HOFGARTNER, Robert J. HARIRI
  • Publication number: 20170252379
    Abstract: Provided herein are compositions of placenta-derived adherent cell exosomes and methods of making and using the same. In one aspect, provided herein are compositions comprising exosomes produced by and/or derived from placental cells, e.g., placenta-derived adherent cells. In certain embodiments, the exosomes provided herein are produced by placenta-derived adherent cells that have been cultured in vitro for, e.g., 1, 2, 3, 4, 5, 6 or more passages.
    Type: Application
    Filed: October 8, 2015
    Publication date: September 7, 2017
    Applicant: Anthrogenesis Corporation
    Inventors: Eric LAW, Andrew MORSCHAUSER, Aleksandar FRANCKI, Jennifer PAREDES, Kathy E. KARASIEWICZ-MENDEZ, Allan REDUTA, Vladimir JANKOVIC, Ivana DJURETIC
  • Publication number: 20170000828
    Abstract: Provided herein are methods of producing enhanced placental stem cells by modulatory RNA molecules. Also provided herein are methods of using enhanced placental stem cells, for example, to treat individuals having a disease, disorder or condition caused by, or relating to, an unwanted or harmful immune response. Further provided herein are compositions comprising said enhanced placental stem cells.
    Type: Application
    Filed: September 22, 2016
    Publication date: January 5, 2017
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, Kathy E. Karasiewicz-Mendez, Vanessa Voskinarian-Berse, Xiaokui Zhang
  • Publication number: 20150190434
    Abstract: Provided herein are methods of producing enhanced placental stem cells by modulatory RNA molecules. Also provided herein are methods of using enhanced placental stem cells, for example, to treat individuals having a disease, disorder or condition caused by, or relating to, an unwanted or harmful immune response. Further provided herein are compositions comprising said enhanced placental stem cells.
    Type: Application
    Filed: January 16, 2015
    Publication date: July 9, 2015
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, Kathy E. Karasiewicz-Mendez, Vanessa Voskinarian-Berse, Xiaokui Zhang
  • Patent number: 8969315
    Abstract: Provided herein are methods of producing enhanced placental stem cells by modulatory RNA molecules. Also provided herein are methods of using enhanced placental stem cells, for example, to treat individuals having a disease, disorder or condition caused by, or relating to, an unwanted or harmful immune response. Further provided herein are compositions comprising said enhanced placental stem cells.
    Type: Grant
    Filed: December 29, 2011
    Date of Patent: March 3, 2015
    Assignee: Anthrogenesis Corporation
    Inventors: Stewart Abbot, Kathy E. Karasiewicz-Mendez, Vanessa Voskinarian-Berse, Xiaokui Zhang
  • Publication number: 20120230959
    Abstract: Provided herein are methods of producing enhanced placental stem cells by modulatory RNA molecules. Also provided herein are methods of using enhanced placental stem cells, for example, to treat individuals having a disease, disorder or condition caused by, or relating to, an unwanted or harmful immune response. Further provided herein are compositions comprising said enhanced placental stem cells.
    Type: Application
    Filed: December 29, 2011
    Publication date: September 13, 2012
    Inventors: Stewart ABBOT, Kathy E. KARASIEWICZ-MENDEZ, Vanessa VOSKINARIAN-BERSE, Xiaokui ZHANG